Global Medical REIT Inc.

Greetings and welcome to the Global Medical Week third quarter 2020 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require an operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Evelyn Inferno. Thank you. You may begin.

Thank you, Operator. Good morning, everyone, and welcome to Global Medical REIT third quarter earnings conference call. On the call today, we have Jeff Bush, Chief Executive Officer, Alfonso Leone, Chief Investment Officer, and Bob Kiernan, Chief Financial Officer. Please note the use of forward-looking statements by the company on this conference call. Statements made on this call may include statements which are not historical facts, and are considered forward-looking, including statements related to the COVID-19 pandemic and its effect on our tenants' business. The company intends these forward-looking statements to be covered by safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and is making the statement for the purpose of complying with those safe harbor provisions. Furthermore, actual results may differ materially from those described in forward-looking statements and will be affected by a variety of risks and factors that are beyond the company's control, including without limitation those contained in the company's 10-K for the year ended December 31, 2019, and Form 10-Q for the quarter ended September 30, 2020, and its other Security and Exchange Commission filings. the company assumes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, on this conference call, the company may refer to non-GAAP financial measures, such as funds from operations and adjusted funds from operations. You can find a tabular reconciliation of these non-GAAP financial measures to most currently comparable GAAP numbers and the company's earnings reliefs and its filings with the Securities Exchange Commission. Additional information may be found on the investor relations page of the company's website at www.globalmedicalreit.com. Please keep in mind that we are doing this call remotely, so given the circumstances, if we have any technical difficulties, just please stand by. I'd like to turn the call over to Jeff Bush, Chief Executive Officer of Global Medical REIT.

Thank you, Evelyn. Good morning, and thank you for joining our third quarter earnings conference call today. Joining me on the call are Alfonso Leon, our chief investment officer, and Bob Kiernan, our chief financial officer. We hope that everyone continues to stay healthy and is doing well. The pandemic continues to test the economy and our industry in a variety of ways. Even in this challenging environment, I am pleased to share that Global Medical continues to perform extremely well. In the third quarter, our AFFO per share and our unit grew 21% compared to last year. And aside from agreed upon deferrals, we collected all our base rent and collected over half the 1.1 million of rent deferrals we extended to our tenants. We continued to find success on the acquisitions front, closing on $171 million of properties year-to-date at an 8% weighted average cap rate. In addition to delivering strong operating results in the third quarter, we reached $1 billion of real estate investment increased our credit facility borrowing capacity by $100 million to $600 million, and completed our management internalization transaction. I am pleased with our accomplishments in such a challenging year. Most importantly, we delivered on our primary business objective in the face of a global health crisis. This reinforces the resilience and reliability of our investment strategy, and we remain diligent and disciplined in our pursuits. Our strategy is aligned with the evolution of the healthcare delivery, and we are excited about the road ahead. With that, I'd like to turn the call over to Alfonso to discuss our acquisition activity.